The Host Cell Protein (HCP) testing market is booming, projected to reach $5 billion by 2033, driven by rising biopharmaceutical demand and stringent regulations. Learn about market trends, key players (GE Healthcare, Thermo Fisher), and the growth of PCR & ELISA-based assays in this comprehensive analysis.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
